(pressebox) Branford, CT, USA, 13.10.2009, A study published online today in the prestigious Nature Medicine journal reports that researchers at the Wisconsin National Primate Research Center have explored a new high-throughput method for decoding one of the most critical genomic regions for the immune system. In the study, they used ultra-deep sequencing with the Genome [...]
Tag Archive > Sequencing Systems
Grundlegende Genotypisierungsstudie demonstriert die Leistungsfähigkeit des 454 Sequencing Systems in der Immungenetik
(pressebox) Branford (Connecticut, USA), 13.10.2009, In einem heute online im renommierten Fachblatt Nature Medicine veröffentlichten Artikel berichtet eine Gruppe von Forschern des amerikanischen Primatenforschungszentrums Wisconsin National Primate Research Center darüber, wie sie eine neue Hochdurchsatzmethode zur Entschlüsselung einer der für das Immunsystem wichtigsten Regionen des Genoms verwendet haben. In der Studie benutzten sie die ultratiefe [...]
Roche and Google.org Start Initiative for Early Discovery of New Diseases
(pressebox) Branford, USA, 28.07.2009, Roche and Google.org recently started a joint project to demonstrate the feasibility of developing a multidisciplinary surveillance, research and response system. This system will enhance the ability to predict and prevent emerging infectious diseases in East Africa. Roche has donated a Genome Sequencer FLX system as backbone of this project."We are [...]
Roche Launches Complete Detection Kit for Influenza A /H1N1 on LightCycler® System
(pressebox) Penzberg, 14.05.2009, Roche Applied Science announced today the availability of a new detection kit for the Influenza A/H1N1 virus. The detection kit is offered for use in life science research. Roche currently is filing to get approval of the local health authorities worldwide for use of the kit in emergency situations. The kit runs [...]
454 Sequencing Systems Enable High Quality De Novo Assembly of Oil Palm Genome
(pressebox) Branford, USA, and Kuala Lumpur, Malaysia, 12.05.2009, At a press conference held today in Kuala Lumpur, Malaysia, a team of researchers announced the complete sequencing, assembly and annotation of the oil palm genome, a key milestone in an effort to enhance productivity and sustainability of this commercially important plant. The initiative also analyzed gene [...]
Roche RT-PCR technology used for TIB MOLBIOL’s H1N1 test
(pressebox) Mannheim, 05.05.2009, TIB MOLBIOL, the Berlin-based cooperation partner of Roche Applied Science announced today the development of a LightMix test for the new variant of the Influenza A H1N1 virus, to be launched initially in Europe and Asia. This test has been optimized for Roche LightCycler® 480 II, 2.0, and 1.2 systems and selectively [...]
Researchers Uncover Low-Frequency Hepatitis B Drug-Resistant Mutations Using 454 Sequencing Systems
(pressebox) Branford, USA, 07.04.2009, A study published online last week in the Journal of Infectious Disease reports that ultra-deep sequencing has the ability to identify low-frequency hepatitis B virus (HBV) drug-resistant mutations in infected samples, including mutations undetected by standard direct PCR sequencing methods (1). The paper outlines the results of a collaborative study between [...]
A 454 Sequencing Study Reveals New Insights in Drug Resistance and Tropism Associated with the New HIV Integrase and Entry Inhibitor Therapy Classes
(pressebox) Branford, USA and Montreal, Canada, 18.02.2009, New data from two studies, presented last week at the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montreal, Canada demonstrate that ultra-deep sequencing with the Genome Sequencer FLX System from 454 Life Sciences, in combination with traditional methods, may provide a deeper understanding of baseline viral [...]
454 Sequencing Identifies Early Stage HIV Drug Resistance / Low-level Mutations may have Significant Impact on Clinical Outcomes
(pressebox) Branford, USA, 17.02.2009, A research study published online this week in the Journal of Infectious Disease reports that HIV resistance mutations present in as little as 1% of the viral population have a significant impact on clinical outcomes. The paper outlines the results of a collaborative study between 454 Life Sciences, a Roche company, [...]
